Sangeeta Aggarwal, MD

Offices

1 location · County of Santa Clara · 1,000 clinicians in this group

Looking this up.

Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.

Plans that list them

6 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aggarwal’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

6 of 6 plans

Sort by

Plans whose provider directory lists this clinician

Central Health Classic Care Plan III (HMO)	Central Health Medicare Plan	Listed	Aug 15, 2026
Central Health Dual Access Plan (HMO D-SNP)	Central Health Medicare Plan	Listed	Aug 15, 2026
Central Health Embrace Care Plan (HMO C-SNP)	Central Health Medicare Plan	Listed, may be out of date	Sep 15, 2025
Central Health Embrace Choice Plan (HMO C-SNP)	Central Health Medicare Plan	Listed	Aug 15, 2026
Central Health Valor Care Plan (HMO)	Central Health Medicare Plan	Listed	Aug 15, 2026
DualConnect (HMO D-SNP)	Santa Clara Family Health Plan	Listed	Sep 1, 2026

California Medical Board record

Licence C52085 · Current

Licensed to practise in California · since 2005 · expires 2027-08-31 · Meerut University, L. L. R. M. Medical College.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend it
Overall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025

See every measure and the patient survey for Santa Clara Valley Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Santa Clara Valley Medical Center

SSI - Colon SurgeryInfections	2.572	Worse	Oct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.563	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.256	Better	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.369	Better	Oct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.25 (0.3 to 2.2) · 1,535 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	1.07 (0.76 to 1.38)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	214.59 (167.38 to 261.8) · 108 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	2.8 · 41 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6 · 141 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	10.2 · 124 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	8.3 · 501 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	14.9 · 653 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	10.1 · 348 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	3 · 4,502 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.24 (0.04 to 0.43) · 9,014 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.34 (0.15 to 0.52) · 9,216 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	4.54 (2.51 to 6.58) · 1,421 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	1.54 (0 to 3.2) · 288 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.11 (0.66 to 3.56) · 1,446 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	11.61 (4.09 to 19.14) · 294 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	7.29 (3.39 to 11.2) · 299 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.9 (0.45 to 3.36) · 333 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.23 (0 to 0.78) · 7,538 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	5.4 · 94 cases	None	Apr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.735	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	2.573	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	14.6 · 185 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	22.1 · 951 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	56.3 · 128 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	6.4 · 644 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	1.3 · 699 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.3 · 921 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.7 (3.9 to 8.1) · 226 cases	No different	Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	12.6 (9.4 to 16.5) · 226 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.4 · 94 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	11.4 · 54 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	20.3 · 242 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	13.2 (9.9 to 17.4) · 702 cases	No different	Jan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	1 (0.7 to 1.4) · 195 cases	No different	Jan 2024 – Dec 2024

What patients said (4,032 patients answered, 29% of those asked)

Sort by

Patient survey stars by topic at Santa Clara Valley Medical Center

Cleanliness	3
Nurse communication	3
Doctor communication	3
Communication about medicines	3
Discharge information	2
Overall hospital rating	3
Quietness	2
Recommend hospital	4

Sort by

Share of patients giving the best answer at Santa Clara Valley Medical Center

Room was "always" clean	70%
Nurses "always" communicated well	73%
Doctors "always" communicated well	76%
Staff "always" explained	57%
Yes, staff "did" give patients this information	82%
Yes, staff "did" give patients information about help after discharge	82%
Doctors "always" explained things so they could understand	71%
Doctors "always" listened carefully	74%
Doctors "always" treated them with courtesy and respect	82%
Patients who gave a rating of "9" or "10" (high)	67%
Staff "always" explained new medications	71%
Nurses "always" explained things so they could understand	71%
Nurses "always" listened carefully	69%
Nurses "always" treated them with courtesy and respect	80%
"Always" quiet at night	43%
"YES", patients would definitely recommend the hospital	70%
Staff "always" explained possible side effects	44%
Yes, staff "did" give patients information about possible symptoms	83%

Original Medicare doctor bills

$52,708

Medicare paid this office $52,708 for 274 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Return visit (30+ min)	172	$22,859	$79
Long return visit (40+ min)	81	$13,233	$125
New patient visit (45+ min)	43	$4,859	$113
Telephone medical discussion with physician, 21-30 minutes	41	$3,377	$70
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	17	$2,352	$107

See all 8 services

Sort by

Every Original Medicare service billed

Return visit (30+ min)	172	$22,859	$79
Long return visit (40+ min)	81	$13,233	$125
New patient visit (45+ min)	43	$4,859	$113
Telephone medical discussion with physician, 21-30 minutes	41	$3,377	$70
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	17	$2,352	$107
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	16	$1,738	$102
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	14	$1,553	$71
Telephone medical discussion with physician, 11-20 minutes	15	$325	$22

Who their Medicare patients are

274 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 12% · Women 74% · Also on Medicaid 78% · Health risk score 1.68. At or below the middle of the specialty; the typical hematology-oncology clinician is at 2.04.

Conditions among them: High blood pressure 72% · Cancer 62% · Diabetes 47% · Chronic kidney disease 19% · Heart failure 17% · Coronary heart disease 16% · COPD 16% · Depression 15% · Atrial fibrillation 13% · Stroke 8% · Dementia 6%.

The office billed $483,826, Medicare allowed $73,463 and paid $52,708; for 601 services of 20 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	274	601	73	1.68	$483,826	$52,708
2023	293	675	72	1.64	$439,224	$52,548
2022	334	821	71	1.55	$411,593	$55,583
2021	300	679	71	1.80	$314,524	$54,749
2020	212	464	69	1.98	$241,887	$32,895
2019	297	799	69	1.72	$595,947	$63,492
2018	154	245	68	2.00	$184,648	$21,721
2015	161	303	68	1.62	$85,643	$19,643
2014	196	418	68	1.60	$121,443	$28,674
2013	201	367	67	1.55	$96,502	$25,302

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 8 services

Sort by

Original Medicare services billed in 2023

Long return visit (40+ min)	86	$15,104	$123
Return visit (30+ min)	108	$11,201	$75
Telephone medical discussion with physician, 11-20 minutes	161	$10,554	$46
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	23	$3,648	$74
New patient visit (45+ min)	31	$3,596	$116
Telephone medical discussion with physician, 21-30 minutes	35	$2,539	$69
Initial hospital care with moderate level of medical decision making at least 75 minutes	16	$2,409	$151
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	12	$1,576	$131

2022: 8 services

Sort by

Original Medicare services billed in 2022

Telephone medical discussion with physician, 11-20 minutes	221	$17,384	$49
Long return visit (40+ min)	47	$8,844	$126
Telephone medical discussion with physician, 21-30 minutes	105	$8,646	$62
Return visit (30+ min)	82	$8,518	$84
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	17	$5,677	$105
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	15	$2,534	$149
Telephone medical discussion with physician, 5-10 minutes	44	$1,212	$22
Short return visit (20+ min)	16	$987	$62

2021: 7 services

Sort by

Original Medicare services billed in 2021

Telephone medical discussion with physician, 21-30 minutes	167	$26,384	$86
Telephone medical discussion with physician, 11-20 minutes	143	$10,472	$59
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	23	$6,102	$107
Return visit (30+ min)	20	$2,504	$93
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	16	$2,317	$136
Long return visit (40+ min)	15	$2,055	$137
Telephone medical discussion with physician, 5-10 minutes	45	$1,769	$32

2020: 6 services

Sort by

Original Medicare services billed in 2020

Telephone medical discussion with physician, 21-30 minutes	82	$10,031	$73
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	24	$6,742	$104
Telephone medical discussion with physician, 11-20 minutes	99	$5,744	$43
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	28	$3,812	$136
Long return visit (40+ min)	44	$3,083	$66
Return visit (30+ min)	15	$1,025	$64

2019: 5 services

Sort by

Original Medicare services billed in 2019

Return visit (30+ min)	202	$21,548	$60
Long return visit (40+ min)	115	$19,122	$95
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	34	$12,118	$93
New patient visit (45+ min)	49	$4,743	$97
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	31	$3,538	$114

2018: 4 services

Sort by

Original Medicare services billed in 2018

Long return visit (40+ min)	57	$7,966	$100
Return visit (30+ min)	85	$6,245	$69
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	15	$2,809	$91
New patient visit (45+ min)	20	$2,306	$115

2015: 1 service

Sort by

Original Medicare services billed in 2015

Return visit (30+ min)	153	$16,814	$61

2014: 3 services

Sort by

Original Medicare services billed in 2014

Return visit (30+ min)	164	$16,993	$58
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	16	$5,253	$91
Initial hospital care with moderate level of medical decision making at least 75 minutes	24	$4,583	$176

2013: 4 services

Sort by

Original Medicare services billed in 2013

Return visit (30+ min)	141	$12,985	$58
Initial hospital care with moderate level of medical decision making at least 75 minutes	20	$3,798	$173
Long return visit (40+ min)	41	$3,117	$76
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	18	$2,890	$61

Medicaid work

$33,798 in 2024

Medicaid paid $33,798 for 3,333 billed services this clinician did in 2024, up to 119 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2024

Return visit (30+ min)	962	$16,001
Long return visit (40+ min)	348	$9,378
New patient visit (45+ min)	125	$4,544
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES	49	$1,767
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES	61	$887
Short return visit (20+ min)	44	$746
IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES	13	$466
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count	35	$9
Pain severity quantified; no pain present (COA) (ONC)	21	$0
Medication list documented in medical record (COA)	603	$0
Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA)	248	$0
Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD)	234	$0

Sort by

Medicaid work by year

2024	3,333	16	119	$33,798
2023	2,002	16	62	$12,079
2022	1,770	11	78	$15,909
2021	2,772	12	69	$24,655
2020	1,362	11	67	$15,338
2019	3,525	14	105	$34,409
2018	3,522	17	70	$30,397

See the largest Medicaid services in earlier years

2023

Sort by

Largest Medicaid services in 2023

Return visit (30+ min)	512	$3,246
Long return visit (40+ min)	394	$3,245
Short return visit (20+ min)	547	$2,521
New patient visit (45+ min)	86	$1,665
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES	100	$1,403
Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM)	113	$0
Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD)	39	$0
Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD)	14	$0
Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM)	13	$0
Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM)	54	$0
Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM)	16	$0
ELECTROLYTE PANEL	12	$0

2022

Sort by

Largest Medicaid services in 2022

Return visit (30+ min)	500	$5,755
Short return visit (20+ min)	646	$4,965
Long return visit (40+ min)	261	$3,388
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES	80	$636
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count	53	$465
ELECTROLYTE PANEL	33	$254
HEPATIC FUNCTION PANEL	48	$237
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	30	$115
Blood glucose (sugar) level	33	$60
Creatinine; blood	53	$27
Urea nitrogen; quantitative	33	$6

2021

Sort by

Largest Medicaid services in 2021

Return visit (30+ min)	432	$7,827
Short return visit (20+ min)	459	$7,063
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count	360	$2,712
Long return visit (40+ min)	135	$1,881
HEPATIC FUNCTION PANEL	337	$1,581
ELECTROLYTE PANEL	211	$1,427
Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique	14	$718
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES	38	$536
Blood glucose (sugar) level	229	$461
Short return visit	76	$339
Creatinine; blood	266	$95
Urea nitrogen; quantitative	215	$15

2020

Sort by

Largest Medicaid services in 2020

Return visit (30+ min)	236	$4,864
Long return visit (40+ min)	90	$2,632
Short return visit (20+ min)	163	$2,133
Service	58	$1,959
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count	150	$1,272
ELECTROLYTE PANEL	102	$790
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES	55	$594
Creatinine; blood	254	$569
HEPATIC FUNCTION PANEL	121	$354
Blood glucose (sugar) level	74	$162
Urea nitrogen; quantitative	59	$8

2019

Sort by

Largest Medicaid services in 2019

Service	300	$10,177
Return visit (30+ min)	897	$6,711
Long return visit (40+ min)	439	$4,819
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES	269	$4,755
Service	338	$2,895
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count	250	$2,179
ELECTROLYTE PANEL	174	$1,352
HEPATIC FUNCTION PANEL	262	$633
Infusion, normal saline solution, 250 cc	84	$413
Blood glucose (sugar) level	176	$283
New patient visit (45+ min)	13	$83
OFF/OP CNSLTJ NEW/EST MOD 40	14	$70

2018

Sort by

Largest Medicaid services in 2018

Service	197	$6,718
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES	187	$4,854
Long return visit (40+ min)	404	$4,179
Service	410	$3,561
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count	340	$2,858
ELECTROLYTE PANEL	245	$1,812
OFF/OP CNSLTJ NEW/EST MOD 40	89	$1,438
Return visit (30+ min)	249	$1,131
Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug	39	$1,115
Injection, heparin sodium, (heparin lock flush), per 10 units	159	$693
HEPATIC FUNCTION PANEL	300	$676
Infusion, normal saline solution, 250 cc	120	$622

Drugs they prescribed that Part D paid

$4,005,391

Pharmacies billed $4,005,391 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 1% of their Part D prescriptions (11 of 980) in 2024. At or below the middle of the specialty; the typical hematology-oncology clinician is at 5%.

712 generic and 268 brand-name prescriptions · $4,005,391 in drug cost · 28 antibiotic prescriptions.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Tagrisso	33	$507,608	$15,382
Scemblix	23	$462,979	$20,130
Ibrance	26	$383,247	$14,740
Tukysa	13	$318,097	$24,469
Imbruvica	18	$294,802	$16,378

See all 25 drugs

Sort by

Every Part D drug this clinician prescribed

Tagrisso	33	$507,608	$15,382
Scemblix	23	$462,979	$20,130
Ibrance	26	$383,247	$14,740
Tukysa	13	$318,097	$24,469
Imbruvica	18	$294,802	$16,378
Lenalidomide	13	$163,666	$12,590
Abiraterone Acetate	38	$111,226	$2,927
Venclexta	17	$75,655	$4,450
Imatinib Mesylate	15	$17,297	$1,153
Aprepitant	17	$10,072	$592
Exemestane	22	$2,546	$116
Anastrozole	135	$2,072	$15
Tamoxifen Citrate	26	$866	$33
Potassium Chloride	13	$656	$50
Prochlorperazine Maleate	37	$570	$15
Acyclovir	47	$377	$8
Loperamide	27	$331	$12
Prednisone	45	$265	$6
Hydroxyurea	13	$243	$19
Gabapentin	25	$201	$8
Losartan	13	$199	$15
Ondansetron	43	$149	$3
Omeprazole	12	$75	$6
Fluconazole	12	$67	$6
Sulfamethoxazole-Trimethoprim	21	$32	$2

Year by year

Sort by

Part D prescribing by year

2024	980	174	1% (11)	27%	$4,005,391
2023	906	160	None	None	$3,307,585
2022	1,330	182	2% (22)	None	$3,369,599
2021	1,462	200	3% (40)	None	$3,821,841
2020	1,296	182	3% (33)	None	$4,298,064
2019	1,226	187	2% (26)	None	$2,993,996
2018	1,186	178	3% (35)	None	$3,147,449
2017	1,244	198	3% (34)	None	$2,310,774
2016	1,003	175	3% (33)	None	$2,314,014
2015	938	155	4% (41)	29%	$1,774,822
2014	843	150	7% (60)	27%	$842,483
2013	900	152	6% (54)	None	$657,599

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 31 drugs

Sort by

Part D drugs prescribed in 2023

Tagrisso	33	$509,386	$15,436
Verzenio	22	$347,190	$15,781
Ibrance	21	$341,003	$16,238
Imbruvica	18	$292,270	$16,237
Sprycel	17	$276,765	$16,280
Pomalyst	15	$268,263	$17,884
Alecensa	13	$218,430	$16,802
Kisqali	15	$205,793	$13,720
Abiraterone Acetate	15	$38,952	$2,597
Aprepitant	27	$13,489	$500
Anastrozole	117	$5,504	$47
Exemestane	12	$2,811	$234
Letrozole	19	$1,728	$91
Tamoxifen Citrate	25	$871	$35
Acyclovir	16	$491	$31
Losartan	14	$476	$34
Gabapentin	33	$467	$14
Ondansetron	49	$386	$8
Prochlorperazine Maleate	22	$355	$16
Loperamide	19	$340	$18
Pregabalin	13	$269	$21
Entecavir	11	$259	$24
Pantoprazole	14	$255	$18
Hydroxyurea	11	$240	$22
Prednisone	34	$204	$6
Levothyroxine	11	$203	$18
Alendronate	12	$191	$16
Omeprazole	15	$157	$10
Dexamethasone	16	$107	$7
Levetiracetam	12	$101	$8
Sulfamethoxazole-Trimethoprim	11	$40	$4

2022: 39 drugs

Sort by

Part D drugs prescribed in 2022

Ibrance	30	$411,333	$13,711
Imbruvica	31	$358,046	$11,550
Sprycel	22	$347,031	$15,774
Pomalyst	15	$300,520	$20,035
Jakafi	16	$280,997	$17,562
Alecensa	14	$225,137	$16,081
Tagrisso	16	$209,772	$13,111
Venclexta	13	$140,489	$10,807
Sandostatin Lar Depot	15	$89,437	$5,962
Abiraterone Acetate	15	$19,408	$1,294
Xarelto	20	$16,561	$828
Exemestane	20	$7,769	$388
Aprepitant	12	$6,172	$514
Anastrozole	142	$4,347	$31
Ondansetron	58	$1,895	$33
Imatinib Mesylate	13	$1,468	$113
Tamoxifen Citrate	46	$1,376	$30
Entecavir	18	$1,286	$71
Acyclovir	74	$1,172	$16
Hydroxyurea	25	$767	$31
Omeprazole	31	$540	$17
Letrozole	26	$528	$20
Gabapentin	37	$477	$13
Mercaptopurine	12	$432	$36
Prochlorperazine Maleate	31	$422	$14
Methotrexate	13	$392	$30
Famotidine	27	$345	$13
Loperamide	18	$342	$19
Oxycodone	13	$286	$22
Pantoprazole	22	$278	$13
Prednisone	36	$243	$7
Sulfamethoxazole-Trimethoprim	23	$207	$9
Alendronate	16	$167	$10
Amlodipine Besylate	25	$166	$7
Levetiracetam	12	$107	$9
Venlafaxine Hcl Er	13	$103	$8
Chlorhexidine Gluconate	17	$72	$4
Zolpidem	11	$68	$6
Furosemide	12	$30	$2

2021: 43 drugs

Sort by

Part D drugs prescribed in 2021

Ibrance	58	$772,109	$13,312
Rydapt	14	$566,119	$40,437
Tagrisso	28	$394,048	$14,073
Sprycel	19	$275,811	$14,516
Imbruvica	26	$243,854	$9,379
Piqray	13	$220,829	$16,987
Alecensa	14	$215,082	$15,363
Venclexta	12	$136,313	$11,359
Sandostatin Lar Depot	17	$115,304	$6,783
Xtandi	12	$107,137	$8,928
Abiraterone Acetate	23	$81,679	$3,551
Procrit	12	$50,647	$4,221
Retacrit	18	$38,100	$2,117
Xarelto	27	$18,523	$686
Exemestane	19	$9,866	$519
Aprepitant	18	$9,377	$521
Anastrozole	150	$3,428	$23
Tamoxifen Citrate	45	$1,562	$35
Entecavir	19	$1,498	$79
Letrozole	37	$997	$27
Acyclovir	64	$864	$14
Gabapentin	61	$779	$13
Hydroxyurea	15	$654	$44
Ondansetron	58	$541	$9
Prochlorperazine Maleate	33	$482	$15
Famotidine	36	$350	$10
Loperamide	20	$321	$16
Dexamethasone	21	$307	$15
Levothyroxine	17	$281	$17
Prednisone	26	$244	$9
Oxycodone-Acetaminophen	14	$235	$17
Venlafaxine Hcl Er	17	$235	$14
Pantoprazole	16	$228	$14
Alendronate	22	$218	$10
Omeprazole	22	$205	$9
Amlodipine Besylate	23	$198	$9
Pravastatin	11	$144	$13
Olanzapine	12	$141	$12
Triamcinolone Acetonide	11	$136	$12
Chlorhexidine Gluconate	17	$130	$8
Hydrocodone-Acetaminophen	11	$111	$10
Sulfamethoxazole-Trimethoprim	16	$86	$5
Zolpidem	14	$57	$4

2020: 34 drugs

Sort by

Part D drugs prescribed in 2020

Ibrance	92	$1,160,849	$12,618
Rydapt	15	$520,305	$34,687
Imbruvica	39	$509,663	$13,068
Sprycel	25	$346,605	$13,864
Lenvima	12	$217,203	$18,100
Alecensa	14	$208,818	$14,916
Zytiga	15	$164,654	$10,977
Revlimid	13	$148,952	$11,458
Kisqali	11	$131,145	$11,922
Sandostatin Lar Depot	17	$114,653	$6,744
Retacrit	13	$22,007	$1,693
Exemestane	20	$15,368	$768
Aprepitant	24	$13,948	$581
Xarelto	22	$13,391	$609
Imatinib Mesylate	13	$3,228	$248
Anastrozole	131	$2,414	$18
Tamoxifen Citrate	56	$2,174	$39
Entecavir	15	$1,222	$81
Prochlorperazine Maleate	52	$915	$18
Letrozole	57	$862	$15
Gabapentin	51	$779	$15
Ondansetron	62	$449	$7
Acyclovir	38	$356	$9
Loperamide	20	$276	$14
Dexamethasone	21	$235	$11
Prednisone	30	$220	$7
Alendronate	25	$215	$9
Levothyroxine	12	$198	$16
Oxycodone	13	$171	$13
Omeprazole	16	$139	$9
Famotidine	14	$120	$9
Allopurinol	21	$110	$5
Amlodipine Besylate	18	$92	$5
Metformin	12	$60	$5

2019: 34 drugs

Sort by

Part D drugs prescribed in 2019

Ibrance	74	$898,537	$12,142
Imbruvica	25	$258,510	$10,340
Alecensa	13	$181,046	$13,927
Sprycel	13	$171,873	$13,221
Promacta	12	$168,254	$14,021
Venclexta	12	$141,123	$11,760
Zytiga	12	$126,837	$10,570
Sandostatin Lar Depot	18	$116,395	$6,466
Aprepitant	18	$14,620	$812
Exemestane	32	$14,322	$448
Xarelto	18	$11,093	$616
Imatinib Mesylate	11	$9,413	$856
Entecavir	16	$3,087	$193
Anastrozole	106	$2,594	$24
Tamoxifen Citrate	53	$2,514	$47
Letrozole	53	$1,157	$22
Ondansetron	80	$562	$7
Prochlorperazine Maleate	54	$554	$10
Dexamethasone	42	$528	$13
Hydroxyurea	12	$486	$40
Gabapentin	29	$463	$16
Megestrol Acetate	11	$429	$39
Acyclovir	30	$394	$13
Ondansetron Odt	15	$303	$20
Hydrocodone-Acetaminophen	13	$282	$22
Amlodipine Besylate	22	$200	$9
Loperamide	13	$196	$15
Prednisone	22	$167	$8
Famotidine	18	$148	$8
Atenolol	14	$144	$10
Pantoprazole	14	$100	$7
Losartan	14	$96	$7
Carvedilol	11	$81	$7
Omeprazole	20	$67	$3

2018: 34 drugs

Sort by

Part D drugs prescribed in 2018

Ibrance	70	$790,446	$11,292
Imbruvica	25	$274,822	$10,993
Revlimid	15	$207,899	$13,860
Sprycel	16	$198,063	$12,379
Promacta	14	$188,552	$13,468
Tasigna	14	$167,436	$11,960
Kisqali	13	$147,936	$11,380
Sandostatin Lar Depot	17	$105,290	$6,194
Bosulif	12	$92,142	$7,679
Tykerb	12	$60,125	$5,010
Imatinib Mesylate	14	$32,433	$2,317
Entecavir	24	$21,480	$895
Exemestane	42	$18,753	$446
Aprepitant	29	$16,263	$561
Xarelto	17	$9,318	$548
Esomeprazole Magnesium	11	$2,551	$232
Tamoxifen Citrate	36	$2,114	$59
Anastrozole	92	$1,620	$18
Letrozole	74	$1,498	$20
Hydroxyurea	17	$428	$25
Ondansetron	34	$387	$11
Acyclovir	28	$355	$13
Dexamethasone	19	$287	$15
Oxycodone	13	$279	$21
Gabapentin	23	$275	$12
Potassium Chloride	12	$264	$22
Prochlorperazine Maleate	18	$258	$14
Granisetron	17	$186	$11
Pantoprazole	22	$162	$7
Atenolol	12	$130	$11
Omeprazole	19	$126	$7
Alendronate	15	$107	$7
Famotidine	15	$105	$7
Amlodipine Besylate	14	$67	$5

2017: 32 drugs

Sort by

Part D drugs prescribed in 2017

Ibrance	60	$669,091	$11,152
Revlimid	22	$289,310	$13,150
Imbruvica	31	$262,920	$8,481
Sandostatin Lar Depot	18	$103,278	$5,738
Afinitor	13	$86,538	$6,657
Imatinib Mesylate	19	$72,524	$3,817
Tykerb	11	$62,028	$5,639
Procrit	15	$37,127	$2,475
Neupogen	11	$28,712	$2,610
Entecavir	29	$23,308	$804
Exemestane	34	$20,157	$593
Xarelto	12	$4,543	$379
Esomeprazole Magnesium	12	$3,221	$268
Tamoxifen Citrate	55	$2,119	$39
Letrozole	119	$2,073	$17
Anastrozole	101	$1,702	$17
Hydroxyurea	23	$564	$25
Levothyroxine	12	$415	$35
Acyclovir	25	$321	$13
Ondansetron	36	$319	$9
Gabapentin	26	$279	$11
Hydrocodone-Acetaminophen	19	$241	$13
Granisetron	22	$238	$11
Prochlorperazine Maleate	30	$201	$7
Pantoprazole	23	$162	$7
Atenolol	16	$160	$10
Omeprazole	24	$159	$7
Alendronate	16	$136	$8
Dexamethasone	11	$117	$11
Amlodipine Besylate	21	$110	$5
Hydrochlorothiazide	11	$67	$6
Famotidine	11	$65	$6

2016: 23 drugs

Sort by

Part D drugs prescribed in 2016

Revlimid	47	$511,364	$10,880
Ibrance	46	$476,751	$10,364
Imbruvica	40	$371,640	$9,291
Pomalyst	21	$206,381	$9,828
Afinitor	20	$159,212	$7,961
Sandostatin Lar Depot	16	$78,387	$4,899
Entecavir	24	$15,495	$646
Exemestane	18	$7,971	$443
Xarelto	12	$2,912	$243
Letrozole	113	$1,894	$17
Tamoxifen Citrate	37	$1,716	$46
Zenpep	12	$1,263	$105
Anastrozole	59	$1,062	$18
Hydroxyurea	15	$555	$37
Hydrocodone-Acetaminophen	15	$373	$25
Gabapentin	37	$373	$10
Alendronate	39	$270	$7
Prednisone	11	$146	$13
Atenolol	13	$140	$11
Pantoprazole	19	$127	$7
Famotidine	21	$127	$6
Dexamethasone	23	$126	$5
Omeprazole	21	$98	$5

2015: 26 drugs

Sort by

Part D drugs prescribed in 2015

Revlimid	50	$487,160	$9,743
Ibrance	26	$259,559	$9,983
Afinitor	22	$165,173	$7,508
Pomalyst	19	$161,524	$8,501
Imbruvica	14	$136,968	$9,783
Gleevec	11	$104,422	$9,493
Exemestane	22	$12,204	$555
Letrozole	120	$1,639	$14
Tamoxifen Citrate	34	$1,155	$34
Zenpep	11	$1,119	$102
Anastrozole	56	$800	$14
Duloxetine	11	$753	$68
Granisetron	26	$687	$26
Hydroxyurea	17	$508	$30
Acyclovir	18	$263	$15
Pantoprazole	28	$213	$8
Gabapentin	20	$171	$9
Atenolol	28	$153	$5
Prochlorperazine Maleate	24	$138	$6
Dexamethasone	33	$131	$4
Ondansetron	12	$109	$9
Alendronate	11	$87	$8
Famotidine	13	$85	$7
Lorazepam	15	$57	$4
Hydrochlorothiazide	14	$51	$4
Amlodipine Besylate	12	$46	$4

2014: 25 drugs

Sort by

Part D drugs prescribed in 2014

Revlimid	23	$239,458	$10,411
Afinitor	25	$228,022	$9,121
Procrit	15	$50,781	$3,385
Exemestane	36	$23,857	$663
Emend	24	$10,027	$418
Anastrozole	76	$3,598	$47
Letrozole	59	$2,092	$35
Tamoxifen Citrate	39	$1,339	$34
Granisetron	33	$1,026	$31
Morphine Sulfate Er	11	$938	$85
Acyclovir	23	$935	$41
Gabapentin	24	$673	$28
Oxycodone-Acetaminophen	14	$578	$41
Hydrocodone-Acetaminophen	16	$406	$25
Hydroxyurea	16	$398	$25
Prochlorperazine Maleate	36	$215	$6
Atenolol	21	$170	$8
Pantoprazole	14	$128	$9
Omeprazole	14	$124	$9
Alendronate	11	$123	$11
Metformin	13	$116	$9
Dexamethasone	17	$86	$5
Amlodipine Besylate	16	$63	$4
Lorazepam	13	$57	$4
Insulin	12	$30	$2

2013: 23 drugs

Sort by

Part D drugs prescribed in 2013

Revlimid	17	$149,945	$8,820
Sandostatin Lar	12	$48,118	$4,010
Procrit	13	$35,335	$2,718
Baraclude	13	$13,031	$1,002
Emend	22	$8,845	$402
Exemestane	34	$6,923	$204
Anastrozole	90	$6,310	$70
Letrozole	82	$4,043	$49
Granisetron	30	$1,117	$37
Tamoxifen Citrate	27	$868	$32
Hydroxyurea	14	$634	$45
Hydrocodone-Acetaminophen	21	$556	$26
Ondansetron	22	$350	$16
Alendronate	27	$327	$12
Omeprazole	19	$307	$16
Metformin	22	$227	$10
Prochlorperazine Maleate	40	$220	$5
Oxycodone-Acetaminophen	11	$216	$20
Atenolol	27	$149	$6
Dexamethasone	30	$133	$4
Amlodipine Besylate	12	$115	$10
Lorazepam	13	$84	$6
Hydrochlorothiazide	12	$58	$5

Money from drug and device companies

$246 in 2025

Sort by

Industry payments by year

2025	1	2	None	$246
2024	2	2	None	$46
2023	1	1	None	$44
2022	1	3	None	$21
2021	4	7	None	$93
2019	2	3	None	$224

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

AstraZeneca Pharmaceuticals LP	Lynparza	$246	2 payments Meals for Lynparza · 2025-12-04 · $121 Meals for Lynparza · 2025-07-17 · $125

See all 2 published payments

Sort by

Every published payment

AstraZeneca Pharmaceuticals LP	Meals · 2025-12-04	Lynparza	$121
AstraZeneca Pharmaceuticals LP	Meals · 2025-07-17	Lynparza	$125

See earlier years (2024, 2023, 2022, 2021, 2019)

2024: $46

Sort by

Payments by company in 2024

EMD Serono	None	$28	1 payment Meals · 2024-08-08 · $28
Merck Sharp & Dohme	Keytruda	$18	1 payment Education for Keytruda · 2024-08-30 · $18

2023: $44

Sort by

Payments by company in 2023

EMD Serono	None	$44	1 payment Education · 2023-09-02 · $44

2022: $21

Sort by

Payments by company in 2022

Pfizer	Bosulif	$21	3 payments Education for Bosulif · 2022-12-05 · $5 Education for Bosulif · 2022-08-16 · $7 Education for Bosulif · 2022-04-08 · $9

2021: $93

Sort by

Payments by company in 2021

Acrotech Biopharma	Beleodaq	$52	4 payments Education for Beleodaq · 2021-09-29 · $12 Education for Beleodaq · 2021-08-23 · $14 Education for Beleodaq · 2021-05-20 · $12 Education for Beleodaq · 2021-03-18 · $14
Ultradent Products	Opalescence	$16	1 payment Meals for Opalescence · 2021-10-07 · $16
Pfizer	Inlyta	$13	1 payment Education for Inlyta · 2021-09-24 · $13
Gilead Sciences	None	$12	1 payment Education · 2021-06-01 · $12

2019: $224

Sort by

Payments by company in 2019

Incyte	Jakafi	$211	2 payments Meals · 2019-06-01 · $100 Meals for Jakafi · 2019-04-18 · $111
Seattle Genetics	Adcetris	$12	1 payment Education for Adcetris · 2019-04-02 · $12

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Sort by

Research payments by company and study

PFIZER INC. · Polaris Palbociclib in Hormone Receptor Positive Advanced Breast Cancer A Prospective Multicenter Noninterventional Study · 2022	Their institution	$20,981
PFIZER INC. · Polaris Palbociclib in Hormone Receptor Positive Advanced Breast Cancer A Prospective Multicenter Noninterventional Study · 2020	Their institution	$3,500

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 80.6 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1225008394
Licence: CA C52085California C52085: Current · expires 2027-08-31
Group: County of Santa Clara
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207RH0003X (207RH0003X); Internal medicine (207R00000X)
Mailing address: 751 S Bascom Ave, Oncology Dept, San Jose, CA, 95128
NPI first listed: 2006-01-23
NPI last updated: 2025-09-11

This is when the NPI record was last certified, not a medical board exam.